Evidence map›Paper›PMID 40685362›Full record

ArticleJournal of nanobiotechnology2025

Injectable HAMA-CPC hydrogels loaded with high-yield 3D bioprinted adipose-derived stem cell small extracellular vesicles for increased bone repair.

Wenbin Xu, Wenling Gao, Yi Zhang, Gang Hou, Wenhui Zhang, Jintao Deng, Kun Wang, Yichun Xu, Boxun Liu, Tao Xu and 2 more

Abstract read
In one paragraph

Article in Journal of nanobiotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Wenbin Xu *Department of Orthopaedic Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, China.
Wenling Gao *Department of Orthodontics, Hospital of Stomatology, Sun Yat-sen University, Guangzhou, 510060, China.
Yi Zhang *Research and Development Department, Huamei Biotech Co. Ltd, Shenzhen, 518107, China.
Gang HouDepartment of Orthopaedic Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, China.
Wenhui ZhangDepartment of Joint and Trauma Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, China.
Jintao DengDepartment of Joint and Trauma Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, China.
Kun WangDepartment of Joint and Trauma Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, China.
Yichun XuDepartment of Orthopaedic Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, China.
Boxun LiuResearch and Development Department, Huamei Biotech Co. Ltd, Shenzhen, 518107, China.
Tao XuCenter for Bio-Intelligent Manufacturing and Living Matter Bioprinting, Research Institute of Tsinghua University in Shenzhen, Shenzhen, 518057, China. xut@tsinghua-sz.org.
Chang LiuDepartment of Orthopaedic Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, China. liuch398@mail2.sysu.edu.cn.
Tangzhao LiangDepartment of Joint and Trauma Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, China. liangtzh5@mail.sysu.edu.cn.

Funding

National Natural Science Foundation of China 82372402Natural Science Foundation of Guangdong Province 2023A1515010386Shenzhen Science and Technology Major Project KJZD20240903102659001
6 · The paper itself

Abstract

In the field of bone tissue engineering, the development of effective strategies for bone defect repair remains a major challenge. Herein, we report a novel approach involving the integration of high-yield 3D bioprinted adipose-derived stem cell small extracellular vesicles (3D-sEVs) into an injectable HAMA-CPC hydrogel (HAMA-CPC@3D-sEVs). In vitro, HAMA-CPC@3D-sEVs significantly promoted the proliferation, migration, and osteogenic differentiation of bone marrow stromal cells (BMSCs) and promoted angiogenesis in human umbilical vein endothelial cells (HUVECs). In vivo, in a rat tibial defect model, this treatment strongly promoted bone regeneration, increasing the bone volume fraction (BV/TV), bone volume (BV), and trabecular thickness (Tb.Th) at 4 weeks post-surgery. Mechanistically, proteomic analysis revealed that NAMPT in 3D-sEVs upregulated S1PR1 in HUVECs, leading to increased VEGF expression and angiogenesis. These findings suggest that 3D-sEVs-functionalized HAMA-CPC hydrogels have good potential for bone defect repair.

Indexed as

BioprintingBone RegenerationCalcium PhosphatesExtracellular VesiclesHydrogelsAdipose TissueAnimalsCell DifferentiationCell ProliferationHumansHuman Umbilical Vein Endothelial CellsMaleMesenchymal Stem CellsNeovascularization, PhysiologicOsteogenesisPrinting, Three-DimensionalCalcium PhosphatesHydrogels3D cultured adipose-derived stem cell small extracellular vesiclesAngiogenesisBone repairCalcium phosphate cement (CPC)Hyaluronic acid methacrylate (HAMA)

Identifiers

PMID40685362
PMCPMC12278526

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.